DNA Sequence Context as a Marker of CpG Methylation Instability in Normal and Cancer Tissues

Scientific Reports - United Kingdom
doi 10.1038/s41598-020-58331-w
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

In Vivo Control of CpG and Non-CpG DNA Methylation by DNA Methyltransferases

PLoS Genetics
EvolutionEcologyGeneticsMolecular BiologyCancer ResearchSystematicsBehavior
2012English

DNA Methylation in Tumor and Matched Normal Tissues From Non-Small Cell Lung Cancer Patients

Cancer Epidemiology Biomarkers and Prevention
MedicineEpidemiologyOncology
2008English

Establishment of a DNA Methylation Marker to Evaluate Cancer Cell Fraction in Gastric Cancer

Gastric Cancer
Cancer ResearchMedicineOncologyGastroenterology
2015English

Promoter Methylation of TRIM9 as a Marker for Detection of Circulating Tumor DNA in Breast Cancer Patients

SpringerPlus
Multidisciplinary
2015English

DNA Methylation as a Therapeutic Target in Cancer

Clinical Cancer Research
Cancer ResearchOncology
2007English

Experimental Mitochondria-Targeted DNA Methylation Identifies GpC Methylation, Not CpG Methylation, as Potential Regulator of Mitochondrial Gene Expression

Scientific Reports
Multidisciplinary
2017English

CpG Island Methylation, Microsatellite Instability, and BRAF Mutations and Their Clinical Application in the Treatment of Colon Cancer

Chemotherapy Research and Practice
2012English

Review of the Development of DNA Methylation as a Marker of Response to Neoadjuvant Therapy and Outcomes in Rectal Cancer

Clinical Epigenetics
GeneticsDevelopmental BiologyMolecular Biology
2015English

Promoter DNA Methylation Analysis Reveals a Combined Diagnosis of CpG-based Biomarker for Prostate Cancer

Oncotarget
Oncology
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy